Alzheimer’s Association provides new guidance for treatment and screening
More than six million Americans age 65 and up are living with Alzheimer’s including more than 35,000 Nebraska residents.
A Breath Away From a Cure: How Xenon Gas Could Transform Alzheimer’s Treatment
A breakthrough study highlights Xenon gas as a potential game-changer in treating Alzheimer’s disease, demonstrating its ...
Rolling Out4d
5 breakthroughs in dementia detection you need to know
Discover how a groundbreaking cognitive assessment tool is transforming early dementia detection with 99.9% accuracy and what ...
Monthly Prescribing Reference3d
Oral SIGMAR1 Targeting Agent Looks Promising in Early Alzheimer Disease Trial
Activation of SIGMAR1 is expected to restore cellular homeostasis by inducing autophagy, which may slow neurodegeneration in patients with early AD.
Xenon gas shows promise in Alzheimer's treatment, leading to clinical trial
Most treatments being pursued today to protect against Alzheimer's disease focus on amyloid plaques and tau tangles that ...
Anavex Life Sciences Shares Rise After Positive Trial Results for Alzheimer's Treatment
Anavex Life Sciences shares were up 7% to $11.25 after the company said it saw positive trial results for its oral blarcamesine for the treatment of early Alzheimer's disease. The clinical-stage ...
Monthly Prescribing Reference1d
Lecanemab SC Formulation Under Review for Early Alzheimer Disease
The Food and Drug Administration (FDA) has accepted the Biologics License Application (BLA) for subcutaneous (SC) maintenance dosing of lecanemab-irmb for the treatment of Alzheimer disease (AD) in ...
Alzheimer’s drugs eyed as next big obesity-like opportunity
Investors seeking the next obesity-like market opportunity will be closely watching developments related to treatments for ...